Actin disruption agents induce phosphorylation of histone H2AX in human breast adenocarcinoma MCF-7 cells

Ik Jae Shin1, Yong-Tae Ahn, Yongkuk Kim

  • 1Joint Research Center of Pusan National University-Fraunhofer IGB, Busan 609-735, Republic of Korea.

Oncology Reports
|March 15, 2011
PubMed

Insights

Targeting modified actin dynamics in cancer cells shows promise for chemotherapy. Actin disruption induces DNA damage, cell cycle arrest, and apoptosis in breast cancer cells, suggesting a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Modified actin dynamics are characteristic of cancer cells, presenting potential therapeutic targets.
  • Actin-disrupting agents like latrunculin B and jasplakinolide offer avenues for cancer treatment.
  • Understanding the precise molecular mechanisms of actin disruption in cancer is crucial.

Purpose of the Study:

  • To investigate the molecular actions of actin disruption in inducing apoptosis via double-strand breaks (DSBs).
  • To analyze the cellular responses, including DNA damage signaling and cell cycle arrest, following actin disruption in cancer cells.

Main Methods:

  • Utilized MCF-7 cancer cells to study the effects of actin disruption.
  • Assessed DNA damage markers (e.g., phosphorylated H2AX), cell cycle progression (G2 arrest), and apoptosis.
  • Investigated the activation of signaling pathways like Erk and the involvement of p53 and p21Cip1/WAF1.
  • Examined the DNA repair mechanisms, specifically homologous recombination (HR), in response to actin disruption.

Main Results:

  • Actin disruption triggered phosphorylation of H2AX, indicating DSBs, and led to G2 cell cycle arrest and apoptosis in MCF-7 cells.
  • Activation of Erk and involvement of p53 were observed in response to DNA damage, without altering p21Cip1/WAF1 levels.
  • MCF-7 cells initiated DNA repair via the homologous recombination pathway to counteract DSBs induced by actin disruption.

Conclusions:

  • Actin plays a significant role in signaling pathways that induce DSBs, homologous recombination repair, and G2 cell cycle arrest in human cancers.
  • Actin disruption emerges as a potential therapeutic strategy for human breast cancer treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
Generation of Straight or Branched Actin Filaments01:14

Generation of Straight or Branched Actin Filaments

The straight or branched structure formation of actin filaments is controlled by nucleating proteins such as the formins and Arp2/3 complex. Formin-mediated assembly results in straight filaments, whereas Arp2/3 protein complex-mediated assembly results in branched actin filaments.
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...